Engaged Capital 13F, Q4 2025

Glenn Welling · quarter ending 31 December 2025 · filed 17 February 2026 · SEC CIK 1559771

$392.02M
Filed US book
9
Positions
24.5%
Largest position

Common stock only: shares the fund reported owning at the quarter end, valued as filed.

Largest positions, Q4 2025

Weights are against the whole filed book. Changes are in shares held, against the Q3 2025 filing.

CompanyTickerValue% of bookvs Q3 2025
V F CORPVFC$95.94M24.5%-10% shares
YETI HLDGS INCYETI$89.78M22.9%-6% shares
BLACKLINE INCBL$59.91M15.3%+139% shares
GXO LOGISTICS INCORPORATEDGXO$43.68M11.1%-15% shares
COGNEX CORPCGNX$33.57M8.6%+9% shares
FRESHPET INCFRPT$24.44M6.2%-35% shares
EVOLENT HEALTH INCEVH$22.26M5.7%unchanged
BRC INCBRCC$15.47M4.0%unchanged
PORTILLOS INCPTLO$6.97M1.8%-70% shares

What changed since Q3 2025

Against the Q3 2025 filing, Engaged Capital opened 0 new positions, added to 2, trimmed 5, left 2 unchanged and exited 0. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.

New positions

No new positions this quarter.

Exited

Nothing from the previous filing was sold outright.

Added to

Trimmed

Other quarters

Source: SEC Form 13F-HR, accession 0000921895-26-000438, filed by Engaged Capital LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.